Business
Vaccine ‘not a panacea’ as surgeries bounce back: Cochlear boss – Sydney Morning Herald
The hearing implant maker is still on the long path back to a COVID normal but can see some light at the end of the tunnel.
When asked exactly how long it will be before all markets had recovered to the same or better levels than before the pandemic, Mr Howitt said it was more likely to be years than months. I think the thing is that the bigger markets where we are in have bounced back quickly, so that is what gives us some confidence. But I think the tail could be quite long.
Cochlears sales in emerging regions, including Latin America and Brazil, were down 30 per cent for the first half (year-on-year), while sales…
-
Noosa News15 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
General19 hours agoGerman palliative care doctor with alleged ‘lust for murder’ accused of killing 15 patients
-
Noosa News24 hours agoTributes flow for Geham wife and mother after husband charged with murder
-
Noosa News15 hours agoHow to find out your TikTok personality – and become a ‘citizen scientist’